Mechanisms Underlying Tolerance of Kidney and islet Allotransplants
肾脏和胰岛同种异体移植耐受的潜在机制
基本信息
- 批准号:8432087
- 负责人:
- 金额:$ 20.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAllogenicAnimalsAntibodiesAntigensAutoimmune DiseasesB-Lymphocyte SubsetsB-LymphocytesBlood CellsBone Marrow CellsBone Marrow TransplantationCellsChimerismChronicClinicalDiseaseGenerationsGraft SurvivalHeartHematopoieticHumanHypersensitivityImmuneImmune responseImmunologic FactorsImmunosuppressionIn VitroInflammatoryInflammatory ResponseInfusion proceduresInstructionIslets of LangerhansKidneyKidney TransplantationKnowledgeLeukocytesMacaca fascicularisMaintenanceMediatingMemoryModelingMonkeysNatureOrganPatientsPreventionPrimatesProceduresProtocols documentationRecoveryRegulationRegulatory T-LymphocyteResistanceSeriesSpecificityStressT cell responseT memory cellTestingTimeTransplantationallograft rejectionallotransplantconditioningdesignimprovedin vivoisletisoimmunitykidney allograftnonhuman primatenovel strategiesprogramsreconstitutionresponse
项目摘要
Our current mixed chimerism has reliably achieved long-term kidney graft survival exclusively in monkeys (60%) displaying low memory T cell reactivity against their donors prior to transplantation in cynomolgus monkeys (5-7). The presence of regulatory T cells (Tregs) capable of suppressing anti-donor inflammatory responses in vitro was consistently detected in tolerant animals. On the other hand, monkeys displaying high
anti-donor memory responsiveness rejected kidney allografts in an acute fashion (6,7). Finally, it is important to note that approximately half of the long-term surviving kidney allografts succumb eventually to chronic rejection (8). These observations stress the need to improve our protocol in order to achieve tolerance to kidney and islet/kidney transplants in 100% of monkeys.
Projects 1 and 2 of this program project propose a series of novel strategies designed to induce tolerance to kidney and islet/kidney allografts in monkeys. Successful tolerance induction in both of these studies rely on the basic principles that prevention/suppression of pro-inflammatory alloimmunity combined with
enhancement of immune regulation will promote tolerogenesis.
Proiect 3 is 1) to investigate the mechanisms by which the in vivo treatments described in Projects 1 and 2 influence the immune response in monkeys transplanted with allogeneic kidneys, islets or islet/kidneys and, 2) elucidate the nature of the cells, soluble factors and immunological mechanisms involved in induction and maintenance of transplant tolerance. This knowledge will help us determine how to select the appropriate
donor/recipient combinations and to refine the treatments proposed in Project 1 and 2 in order to reliably achieve tolerance to kidney and islet transplants in primates. To study this, we propose the following Aims:
Specific aim 1. Investigate donor hematopoietic mixed chimerism, leukocyte recovery and deleterious alloimmune T cell responses in transplanted monkeys
Specific aim 2. Investigate regulatory T cell responses associated with transplant tolerance
Specific aim 3. Investigate B cell responses and their contribution to rejection and tolerance
Understanding the mechanisms by which tolerance is induced and maintained in our primate transplant model should significantly expand the successful application of tolerance protocols in clinical transplantation and for the treatment of immune-mediated diseases requiring tolerogenesis of harmful memory T cells in patients such as autoimmune disorders and allergies.
我们目前的混合嵌合体仅在猴子 (60%) 中可靠地实现了肾移植的长期存活,在移植到食蟹猴 (5-7) 之前,这些猴子对其供体表现出低记忆 T 细胞反应性。在耐受动物中始终检测到能够在体外抑制抗供体炎症反应的调节性 T 细胞 (Treg) 的存在。另一方面,猴子表现得很高
抗供体记忆反应以急性方式排斥同种异体肾移植物 (6,7)。最后,值得注意的是,大约一半的长期存活的同种异体肾移植物最终死于慢性排斥反应 (8)。这些观察结果强调需要改进我们的方案,以实现 100% 猴子对肾脏和胰岛/肾脏移植的耐受性。
该计划项目的项目 1 和项目 2 提出了一系列新颖的策略,旨在诱导猴子对肾脏和胰岛/肾脏同种异体移植物的耐受性。这两项研究中成功的耐受诱导依赖于预防/抑制促炎同种免疫与
免疫调节的增强将促进耐受性的发生。
项目 3 是 1) 研究项目 1 和 2 中描述的体内治疗影响移植同种异体肾脏、胰岛或胰岛/肾脏的猴子的免疫反应的机制,2) 阐明细胞、可溶性因子的性质以及涉及诱导和维持移植耐受的免疫机制。这些知识将帮助我们确定如何选择合适的
供体/受体组合,并完善项目 1 和 2 中提出的治疗方法,以便可靠地实现灵长类动物对肾脏和胰岛移植的耐受性。为了研究这个问题,我们提出以下目标:
具体目标 1. 研究移植猴中供体造血混合嵌合、白细胞恢复和有害同种免疫 T 细胞反应
具体目标 2. 研究与移植耐受相关的调节性 T 细胞反应
具体目标 3. 研究 B 细胞反应及其对排斥和耐受的贡献
了解在我们的灵长类移植模型中诱导和维持耐受性的机制将显着扩大耐受方案在临床移植中的成功应用,以及治疗需要患者体内有害记忆 T 细胞耐受的免疫介导疾病,例如自身免疫性疾病和免疫性疾病。过敏。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GILLES A BENICHOU其他文献
GILLES A BENICHOU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GILLES A BENICHOU', 18)}}的其他基金
Core A: Elucidating the Mechanisms Underlying Mixed-Chimerism Based Tolerance
核心 A:阐明基于混合嵌合体的耐受性的潜在机制
- 批准号:
10457399 - 财政年份:2021
- 资助金额:
$ 20.36万 - 项目类别:
Core A: Elucidating the Mechanisms Underlying Mixed-Chimerism Based Tolerance
核心 A:阐明基于混合嵌合体的耐受性的潜在机制
- 批准号:
10673073 - 财政年份:2021
- 资助金额:
$ 20.36万 - 项目类别:
Core A: Elucidating the Mechanisms Underlying Mixed-Chimerism Based Tolerance
核心 A:阐明基于混合嵌合体的耐受性的潜在机制
- 批准号:
10270359 - 财政年份:2021
- 资助金额:
$ 20.36万 - 项目类别:
Exosomes and Donor Antigen Cross-dressing in Pancreatic Islet Transplantation
胰岛移植中的外泌体和供体抗原异装
- 批准号:
10062499 - 财政年份:2017
- 资助金额:
$ 20.36万 - 项目类别:
Exosomes and Donor MHC Cross-Dressing of Recipient Cells in Allotransplantation
同种异体移植中受体细胞的外泌体和供体 MHC 交叉搭配
- 批准号:
9090279 - 财政年份:2016
- 资助金额:
$ 20.36万 - 项目类别:
B Cells in Tolerance and Chronic Rejection of Monkey Kidney Allografts
B 细胞对猴肾同种异体移植物的耐受性和慢性排斥
- 批准号:
9244900 - 财政年份:2016
- 资助金额:
$ 20.36万 - 项目类别:
Mechanisms Underlying Delayed Transplant Tolerance
延迟移植耐受的潜在机制
- 批准号:
8990982 - 财政年份:2015
- 资助金额:
$ 20.36万 - 项目类别:
Effects of Lymphangiogenesis Blockade on Skin Allograft Rejection
淋巴管生成阻断对皮肤同种异体移植排斥的影响
- 批准号:
8417661 - 财政年份:2012
- 资助金额:
$ 20.36万 - 项目类别:
Mechanisms Underlying Tolerance of Kidney and islet Allotransplants
肾脏和胰岛同种异体移植耐受的潜在机制
- 批准号:
8725787 - 财政年份:2012
- 资助金额:
$ 20.36万 - 项目类别:
Effects of Lymphangiogenesis Blockade on Skin Allograft Rejection
淋巴管生成阻断对皮肤同种异体移植排斥的影响
- 批准号:
8302693 - 财政年份:2012
- 资助金额:
$ 20.36万 - 项目类别:
相似国自然基金
抗骨髓瘤的新型同种异体嵌合抗原受体T(CAR T)细胞疗法研发
- 批准号:82270210
- 批准年份:2022
- 资助金额:68 万元
- 项目类别:面上项目
过表达MicroRNA-199a-3p的BMSCs来源的外泌体抑制小鼠DC功能诱导同种异体心脏移植免疫耐受的机制研究
- 批准号:82160081
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
胸腺上皮细胞在小鼠后肢同种异体复合组织移植中的免疫调节作用及相关机制研究
- 批准号:82102354
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
具有靶向识别和序贯治疗功能的纳米微球对血管化同种异体复合组织移植术后免疫抑制的研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
基于T细胞亚群分化与TLR2/TRAF6信号通路探讨ESAT-6抑制同种异体移植排斥的分子免疫机制
- 批准号:82071800
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of Chronic Pancreatitis and Its Associated Pain
间充质干细胞治疗慢性胰腺炎及其相关疼痛的安全性和有效性
- 批准号:
10721284 - 财政年份:2023
- 资助金额:
$ 20.36万 - 项目类别:
Targeted conditioning to maximize prenatal HSC engraftment for SCD
针对性调节以最大限度地提高 SCD 的产前 HSC 植入
- 批准号:
10654382 - 财政年份:2023
- 资助金额:
$ 20.36万 - 项目类别:
Nanowired human isogenic cardiac organoids to treat acute myocardial ischemia/reperfusion injuries
纳米线人类同基因心脏类器官治疗急性心肌缺血/再灌注损伤
- 批准号:
10721208 - 财政年份:2023
- 资助金额:
$ 20.36万 - 项目类别:
A Novel Small Molecule Therapeutic for Acute Graft Versus Host Disease
一种治疗急性移植物抗宿主病的新型小分子疗法
- 批准号:
10759657 - 财政年份:2023
- 资助金额:
$ 20.36万 - 项目类别:
Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation
粪便微生物群移植和纤维治疗造血细胞移植后移植物抗宿主病
- 批准号:
10737446 - 财政年份:2023
- 资助金额:
$ 20.36万 - 项目类别: